Document is current
Any future updates will be listed below
-
Authors
Cheng, Anna
Badolato, Ryan
Segoshi, Andrew
McDonald, Ryan
Malone, Mia
Vasudevan, Kumar
Badiei, Beita
Sugarman, Allison
Macdonald, Ross
Mangat, Jasdeep
Giftos, Jonathan
Lee, Joshua D.
Tofighi, Babak http://orcid.org/0000-0001-7393-7564
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (U01-DA033336-05S1, K23DA042140-01A1)
- License Information
-
More Information
Article History
Received: 12 August 2021
Accepted: 18 January 2022
First Online: 29 January 2022
Declarations
:
: This study was approved by the Institutional Review Board of the New York University Grossman School of Medicine and met criteria for allowable Federally funded research among prisoners per the Office of Human Research Protections.
: Not applicable.
: JDL has received in-kind study drugs from Indivior and Alkermes for other OUD clinical trials. JDL has received an Investigator Sponsored Study grant from Indivior for an unrelated study. JDL is a Science Advisor to Oar Health, an alcohol treatment product.
